Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Wilcken

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Australian and New Zealand Journal of Medicine|October 1, 1992
Safety of post-menopausal hormone replacementN Wilcken
The New England Journal of Medicine|September 26, 1997
Winning the war on cancerN Wilcken
Cancer|September 15, 1991
Endocrine therapy for desmoid tumorsN Wilcken, M H Tattersall
The Cochrane Database of Systematic Reviews|June 14, 2003
Chemotherapy alone versus endocrine therapy alone for metastatic breast cancerN Wilcken, J Hornbuckle, D Ghersi
The Cochrane Database of Systematic Reviews|July 21, 2006
Addition of drug/s to a chemotherapy regimen for metastatic breast cancerD Jones, D Ghersi, N Wilcken
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Chemotherapy for metastatic breast cancer--when is enough enough?M Stockler, N Wilcken, A Coates
British Journal of Cancer|July 30, 2005
A systematic review of taxane-containing regimens for metastatic breast cancerD Ghersi, N Wilcken, R J Simes
The Cochrane Database of Systematic Reviews|July 22, 2004
Platinum containing regimens for metastatic breast cancerS Carrick, D Ghersi, N Wilcken, et al.
The Cochrane Database of Systematic Reviews|August 15, 2003
Taxane containing regimens for metastatic breast cancerD Ghersi, N Wilcken, J Simes, et al.
The Cochrane Database of Systematic Reviews|April 24, 2004
Platinum containing regimens for metastatic breast cancerS Carrick, D Ghersi, N Wilcken, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Australian and New Zealand Journal of Medicine|October 1, 1992
Safety of post-menopausal hormone replacementN Wilcken
The New England Journal of Medicine|September 26, 1997
Winning the war on cancerN Wilcken
Cancer|September 15, 1991
Endocrine therapy for desmoid tumorsN Wilcken, M H Tattersall
The Cochrane Database of Systematic Reviews|June 14, 2003
Chemotherapy alone versus endocrine therapy alone for metastatic breast cancerN Wilcken, J Hornbuckle, D Ghersi
The Cochrane Database of Systematic Reviews|July 21, 2006
Addition of drug/s to a chemotherapy regimen for metastatic breast cancerD Jones, D Ghersi, N Wilcken
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Chemotherapy for metastatic breast cancer--when is enough enough?M Stockler, N Wilcken, A Coates
British Journal of Cancer|July 30, 2005
A systematic review of taxane-containing regimens for metastatic breast cancerD Ghersi, N Wilcken, R J Simes
The Cochrane Database of Systematic Reviews|July 22, 2004
Platinum containing regimens for metastatic breast cancerS Carrick, D Ghersi, N Wilcken, et al.
The Cochrane Database of Systematic Reviews|August 15, 2003
Taxane containing regimens for metastatic breast cancerD Ghersi, N Wilcken, J Simes, et al.
The Cochrane Database of Systematic Reviews|April 24, 2004
Platinum containing regimens for metastatic breast cancerS Carrick, D Ghersi, N Wilcken, et al.
Pageof 3